Company / Operating Margin
Phio Pharmaceuticals Corp. Operating Margin History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-42795.2%
FY2020
5-year range
-93746.7% / -5336.2%
FY2016-FY2020
Trend
-702.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -702% YoY in FY2020, a notable deviation from the 6-year average annual change of -148%.
Based on SEC 10-K filings.
-42795.2% in FY2020 with a 3-year CAGR of +4652.1%.
Improved from -93746.7% to -42795.2% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +4652.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2020, operating margin decreased 702.0% year-over-year.
- Peak operating margin was recorded in FY2019.
- Lowest operating margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -42795.2% | -702.0% |
| FY2019 | -5336.2% | +94.3% |
| FY2018 | -93746.7% | -97.6% |
| FY2017 | -47447.4% | -57.6% |
| FY2016 | -30108.8% | -125.1% |
| FY2013 | -13376.3% | -1.6% |
| FY2012 | -13164.9% | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026